Company / Revenue per Share
EyePoint, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.46
FY2025
5-year range
$0.46 / $1.90
FY2021-FY2025
Trend
-51.0%
vs FY2024
Sector context
#150 of 153
Health Care
What the data says
Among 153 Health Care companies, EyePoint, Inc. is in the bottom 2% for revenue per share. Revenue per Share has declined for 4 consecutive years, from $1.90 in FY2021 to $0.46 in FY2025.
Based on SEC 10-K filings.
0.46 in FY2025 with a 5-year CAGR of -24.4%.
Declined from $1.21 to $0.46 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -24.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 153This company $0.46 Sector average $123.62
▼
-99.6% below sector average
Key checks
Key Insights
- EyePoint, Inc.'s revenue per share has declined for 4 consecutive years.
- In FY2025, revenue per share decreased 51.0% year-over-year.
- Ranks #150 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | -51.0% |
| FY2024 | $0.94 | -22.8% |
| FY2023 | $1.21 | -0.5% |
| FY2022 | $1.22 | -35.7% |
| FY2021 | $1.90 | +2.0% |
| FY2020 | $1.86 | +2254.6% |
| FY2019 | $0.08 | +5.1% |
| FY2018 | $0.08 | +335.8% |
| FY2017 | $0.02 | -68.7% |
| FY2016 | $0.06 | -24.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026